Skip to main content

Genitourinary Cancer

  • Chapter
  • First Online:
Intraoperative Irradiation

Abstract

Radical cystectomy, with a pelvic lymph-node dissection, is considered the standard treatment for invasive bladder cancer. The optimal goals of treatment for any invasive bladder cancer should include long-term survival, prevention of both pelvic relapse and development of metastases and an excellent quality of life. This treatment has achieved excellent oncological results with 7% local relapse rates and 5- and 10-year disease-free survival rates of 68 and 60%, respectively [1]. However, radical cystectomy results in erectile impotence, infertility, and involves the problem of urinary diversions compromising the quality of life.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Stein JP, Lieskovsky G, Cote R, et al. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol. 2001;19:666–75.

    PubMed  CAS  Google Scholar 

  2. Matsumoto L, Kazizoe T, Mikuriya S, et al. Clinical evaluation of intraoperative radiotherapy for carcinoma of the urinary bladder. Cancer. 1981;47:509–13.

    Article  PubMed  CAS  Google Scholar 

  3. van der Werf-Messing B, Menon RS, Hop WL. Cancer of the urinary bladder T2, T3, (NXMO) treated by interstitial radium implant: second report. Int J Radiat Oncol Biol Phys. 1983;7:481–5.

    Google Scholar 

  4. Mazeron JJ, Marinello G, Pierquin B, et al. Treatment of bladder tumors by iridium-192 implantation: the Creteil technique. Radiother Oncol. 1985;4:111–9.

    Article  PubMed  CAS  Google Scholar 

  5. Batterman JJ, Tierie AH. Results of implantation for T1 and T2 bladder tumors. Radiother Oncol. 1986;5:85–90.

    Article  Google Scholar 

  6. Calvo FA, Henriquez I, Santos M, et al. Intraoperative and external beam radiotherapy in invasive bladder cancer: pathological findings following cystectomy. Am J Clin Oncol. 1990;13:101–6.

    Article  PubMed  CAS  Google Scholar 

  7. Calvo FA, Aristu J, Abuchaibe O, et al. Intraoperative and external preoperative radiotherapy in invasive bladder cancer: effect of neoadjuvant chemotherapy in tumor downstaging. Am J Clin Oncol. 1993;16:61–6.

    Article  PubMed  CAS  Google Scholar 

  8. Gerard JP, Hulewicz G, Saleh M, et al. Pilot study of IORT for bladder carcinoma. Front Radiat Ther Oncol. 1997;31:250–2.

    Article  PubMed  CAS  Google Scholar 

  9. Hulewicz G, Roy P, Coquard R, et al. Peroperative radiotherapy in the conservative treatment of infiltrating bladder cancers. Prog Urol. 1997;7:229–34.

    PubMed  CAS  Google Scholar 

  10. Blank LE, Koedooder K, van Os R, et al. Results of bladder-conserving treatment, consisting of brachytherapy combined with limited surgery and external beam radiotherapy, for patients with solitary T1-T3 bladder tumors less than 5 cm in diameter. Int J Radiat Oncol Biol Phys. 2007;69:454–8.

    Article  PubMed  Google Scholar 

  11. Thariat J, Caullery M, Ginot A, et al. State of the art and advances in radiotherapy for bladder cancer. Prog Urol. 2009;19:85–93.

    Article  PubMed  CAS  Google Scholar 

  12. van der Steen-Banasik E, Ploeg M, Witjes JA, et al. Brachytherapy versus cystectomy in solitary bladder cancer: a case control, multicentre, East-Netherlands study. Radiother Oncol. 2009;93:352–7.

    Article  PubMed  Google Scholar 

  13. van Onna IE, Oddens JR, Kok ET, et al. External beam radiation therapy followed by interstitial radiotherapy with iridium-192 for solitary bladder tumours: results of 111 treated patients. Eur Urol. 2009;56:113–22.

    Article  PubMed  Google Scholar 

  14. Mak RH, Zietman AL, Heney NM, et al. Bladder preservation: optimizing radiotherapy and integrated treatment strategies. BJU Int. 2008;102:1345–53.

    Article  PubMed  Google Scholar 

  15. Kachnic LA, Kaufman DS, Heney NM, et al. Bladder preservation by combined modality therapy for invasive bladder cancer. J Clin Oncol. 1997;15:1022–9.

    PubMed  CAS  Google Scholar 

  16. Shipley WU, Kaufman DS, Prout GR. Intraoperative radiation therapy in patients with bladder cancer. A review of techniques allowing improved tumor doses and providing high cure rates without loss of the bladder function. Cancer. 1987;60:1485–8.

    Article  PubMed  CAS  Google Scholar 

  17. Shipley WU. Intraoperative radiation therapy for bladder cancer: a review of techniques allowing improved tumor doses and providing high cure rates without the loss of bladder function. In: Dobelbower RR, Abe M, editors. Intraoperative radiation therapy. Boca Raton, FL: CRC; 1989. p. 227–33.

    Google Scholar 

  18. Matsumoto K. Intraoperative radiation therapy for bladder cancer. In: Dobelbower RR, Abe M, editors. Intraoperative radiation therapy. Boca Raton, FL: CRC; 1989. p. 217–26.

    Google Scholar 

  19. Rostom YA, Chapet O, Russo SM, et al. Intra-operative electron radiotherapy as a conservative treatment for infiltrating bladder cancer. Eur J Cancer. 2000;36:1781–7.

    Article  PubMed  CAS  Google Scholar 

  20. Nieuwenhuijzen JA, Pos F, Moonen LMF, et al. Survival after bladder-preservation with brachytherapy versus radical cystectomy; a single institution experience. Eur Urol. 2005;48:239–45.

    Article  PubMed  CAS  Google Scholar 

  21. van Poppel H, Lievens Y, Van Limbergen E, et al. Brachytherapy with iridium-192 for bladder cancer. Eur Urol. 2000;37:605–8.

    Article  PubMed  Google Scholar 

  22. De Crevoisier R, Ammor A, Court B, et al. Bladder-conserving surgery and interstitial brachytherapy for lymph node negative transitional cell carcinoma of the urinary bladder: results of a 28-year single institution experience. Radiother Oncol. 2004;72:147–57.

    Article  PubMed  Google Scholar 

  23. Chung HT, Speight JL, Roach III M. Intermediate- and high risk prostate cancer. In: Halperin EC, Perez CA, Brady LW, editors. Principles and practice of radiation oncology. 5th ed. Philadelphia, PA: Wolters Kluver – Lippincott Williams & Wilkins; 2008. p. 1483–502.

    Google Scholar 

  24. Terrone C, Gontero P, Volpe A, et al. Proposal of an improved prognostic classification for pT3 renal cell carcinoma. J Urol. 2008;180:72–8.

    Article  PubMed  CAS  Google Scholar 

  25. Fugitt RB, Wu GS, Martinelli LC. An evaluation of postoperative radiotherapy in hypernephroma treatment – a clinical trial. Cancer. 1973;32:1332–40.

    Article  PubMed  CAS  Google Scholar 

  26. van der Werf-Messing B. Proceedings: carcinoma of the kidney. Cancer. 1973;32:1056–61.

    Article  PubMed  Google Scholar 

  27. Juusela H, Malmio K, Alfthan O, et al. Preoperative irradiation in the treatment of renal adenocarcinoma. Scand J Urol Nephrol. 1977;11:277–81.

    Article  PubMed  CAS  Google Scholar 

  28. Kjaer M, Frederiksen PL, Engelholm SA. Postoperative radiotherapy in stage II and III renal adenocarcinoma.A randomized trial by the Copenhagen Renal Cancer Study Group. Int J Radiat Oncol Biol Phys. 1987;13:665–72.

    Article  PubMed  CAS  Google Scholar 

  29. Rabinovitch RA, Zelefsky MJ, Gaynor JJ, et al. Patterns of failure following surgical resection of renal cell carcinoma: implications for adjuvant local and systemic therapy. J Clin Oncol. 1994;12:206–12.

    PubMed  CAS  Google Scholar 

  30. Beitler JJ, Makara D, Silverman P, et al. Definitive, high-dose-per-fraction, conformal, stereotactic external radiation for renal cell carcinoma. Am J Clin Oncol. 2004;27:646–8.

    Article  PubMed  Google Scholar 

  31. Frydenberg M, Gunderson LL, Hahn G, et al. Preoperative external beam radiotherapy followed by cytoreductive surgery and intraoperative radiotherapy for locally advanced primary or recurrent renal malignancies. J Urol. 1995;152:15–21.

    Google Scholar 

  32. Haddock MG, Miller RC, Zincke H, Gunderson LL. Intraoperative electron irradiation (IOERT) for locally advanced genitourinary malignancies. Proc. 3rd ISIORT Meeting, Aachen, Germany, 11–14 Sep 2002.

    Google Scholar 

  33. Santos M, Ucar A, Ramos H, et al. Radioterapia intraoperatoria en el carcinoma renal localmente avanzado: experiencia inicial. Actas Urol Esp. 1989;13:36–40.

    PubMed  CAS  Google Scholar 

  34. Eble MJ, Staehler G, Wannenmacher M. Intraoperative radiotherapy (IORT) for locally advanced or recurrent renal cell carcinoma. Strahlenther Onkol. 1998;174:30–6.

    Article  PubMed  CAS  Google Scholar 

  35. Master VA, Gottschalk AR, Kane C, et al. Management of isolated renal fossa recurrence following radical nephrectomy. J Urol. 2005;174:473–7.

    Article  PubMed  Google Scholar 

  36. Saracino B, Gallucci M, De Carli P, et al. G. Phase I-II study of intraoperative radiation therapy (IORT) after radical prostatectomy for prostate cancer. Int J Radiat Oncol Biol Phys. 2008;71:1049–56.

    Article  PubMed  Google Scholar 

  37. Takahashi M, Okada K, Shibamoto Y, et al. Intraoperative radiotherapy in the definitive treatment of localized carcinoma of the prostate. Int J Radiat Oncol Biol Phys. 1985;11:147–51.

    Article  PubMed  CAS  Google Scholar 

  38. Abe M, Takahashi M, Shibamoto Y, et al. Intraoperative radiation therapy for prostatic cancer. In: Vaeth JM, Meyer JL, editors. The role of high energy electrons in the treatment of cancer. Basel: Karger; 1991. Front Radiat Ther Oncolol;25:317–321.

    Google Scholar 

  39. Higashi Y, Hyochi N, Tari K. Intraoperative radiotherapy combined with external beam radiation for prostate cancer without metastasis. Nippon Rinsho. 1998;56:2177–80.

    PubMed  CAS  Google Scholar 

  40. Kojima S, Satake I, Tujii T, et al. Intraoperative radiotherapy (IORT) in prostatic cancer. Hinyokika Kiyo. 1988;34:1397–402.

    Google Scholar 

  41. Orecchia R, Jereczek-Fossa BA, Ciocca M, et al. Intraoperative radiotherapy for locally advanced prostate cancer: treatment technique and ultrasound-based analysis of dose distribution. Anticancer Res. 2007;27:3471–6.

    PubMed  Google Scholar 

  42. Krengli M, Terrone C, Ballarè A, et al. Intra-operative radiotherapy (IORT) during radical prostatectomy for locally advanced prostate cancer: technical and dosimetrical aspects. Int J Radiat Oncol Biol Phys. 2010;76:1073–7.

    Article  PubMed  Google Scholar 

  43. Ravi R, Vasanthan A. Intraoperative irradiation: another option for the treatment of ≥3 cm residual mass following chemotherapy for advanced testicular seminoma. Urol Int. 1995;55:137–40.

    Article  PubMed  CAS  Google Scholar 

  44. Cromheecke M, Mehta DM, Sleijfer DT, et al. The ultimate effect of intraoperative radiotherapy (IORT) on an irresectable retroperitoneal recurrence of a non-seminomatous testicular tumour. Radiother Oncol. 1993;29:352–6.

    Article  PubMed  CAS  Google Scholar 

  45. Kinsella TJ, Sindelar WF, DeLuca AM, et al. Tolerance of the canine bladder to intraoperative radiation therapy: an experimental study. Int J Radiat Oncol Biol Phys. 1988;14:939–46.

    Article  PubMed  CAS  Google Scholar 

  46. Hoekstra HJ, Sindelar WF, Kinsella TJ, et al. Intraoperative radiation therapy-induced sarcomas in dogs. Radiat Res. 1989;120:508–15.

    Article  PubMed  CAS  Google Scholar 

  47. Shaw EG, Gunderson LL, Martin JK, et al. Peripheral nerve and ureteral tolerance to intraoperative radiation therapy: clinical and dose response analysis. Radiother Oncol. 1990;18:247–55.

    Article  PubMed  CAS  Google Scholar 

  48. Miller RC, Haddock MG, Petersen IA, et al. Intraoperative electron-beam radiotherapy and ureteral obstruction. Int J Radiat Oncol Biol Phys. 2006;64:792–8.

    Article  PubMed  Google Scholar 

  49. Dunst J, Sauer R, Schrott KM, et al. An organ-sparing treatment of advanced bladder cancer: a 10-year experience. Int J Radiat Oncol Biol Phys. 1994;30:261–6.

    Article  PubMed  CAS  Google Scholar 

  50. Schultz TK, Herr HW, Zhang ZF, et al. Neoadjuvant chemotherapy for invasive bladder cancer: prognostic factors for survival in patients treated with MVAC with 5-year follow-up. J Clin Oncol. 1994;12:1394–401.

    PubMed  CAS  Google Scholar 

  51. Tester W, Caplan R, Heaney J, et al. Neoadjuvant combined modality program with selective organ preservation for invasive bladder cancer: results of Radiation Therapy Oncology Group phase II trial 8802. J Clin Oncol. 1996;14:119–26.

    PubMed  CAS  Google Scholar 

  52. Fowler JF. The radiobiology of prostate cancer including new aspects of fractionated radiotherapy. Acta Oncol. 2005;44:265–76.

    Article  PubMed  Google Scholar 

  53. Bolla M, van Poppel H, Collette L, et al. Postoperative radiotherapy after radical prostatectomy: a randomised controlled trial (EORTC trial 22911). Lancet. 2005;366:572–8.

    Article  PubMed  Google Scholar 

  54. Thompson Jr IM, Tangen CM, Paradelo J, et al. Adjuvant radiotherapy for pathologically advanced prostate cancer: a randomized clinical trial. JAMA. 2006;296:2329–35.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Marco Krengli .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Krengli, M. et al. (2011). Genitourinary Cancer. In: Gunderson, L., Willett, C., Calvo, F., Harrison, L. (eds) Intraoperative Irradiation. Current Clinical Oncology. Humana Press. https://doi.org/10.1007/978-1-61779-015-7_21

Download citation

  • DOI: https://doi.org/10.1007/978-1-61779-015-7_21

  • Published:

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-61779-014-0

  • Online ISBN: 978-1-61779-015-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics